Efficacy of Traditional Chinese Medicine Combined with Selective Serotonin Reuptake Inhibitors on the Treatment for Parkinson's Disease with Depression: A Systematic Review and Meta-Analysis
- PMID: 33657988
- DOI: 10.1142/S0192415X21500282
Efficacy of Traditional Chinese Medicine Combined with Selective Serotonin Reuptake Inhibitors on the Treatment for Parkinson's Disease with Depression: A Systematic Review and Meta-Analysis
Abstract
Depression is a common neuropsychiatric symptom of Parkinson's disease (PD), resulting in a lower quality of life and cognitive impairment in PD patients. Traditional Chinese medicine (TCM) formulas have been widely used in neurodegenerative disease and neuropsychic disorders to improve life quality of patients in ethnomedicine. TCM formulas combined with selective serotonin reuptake inhibitors (SSRIs) also have a positive effect on depressed PD compared with SSRIs as reported by several clinical studies. However, the results are discordant and failed to be conclusive. We aim to evaluate the efficacy of TCM formulas combined with SSRIs for depressed PD in this systematic review. We searched literatures from PubMed, Web of Science, Medline, Embase, Google Scholar, Chinese National Knowledge Infrastructure, Wanfang Database, and VIP Information Database before July 2020. We included randomized controlled trials investigating the efficacy of TCM formulas combined with SSRIs on depressed PD patients. This analysis was according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. Eleven randomized clinical trials involving 861 subjects were enrolled in this analysis. The overall results showed that TCM formulas combined with SSRIs significantly improved the depression score [weighted mean difference (WMD): -4.920, 95% confidence interval (CI): (-5.999, -3.840); [Formula: see text]¡ 0.001] and had a statistical significance on Unified Parkinson's Disease Rating Scale II score [WMD: -1.209, 95% CI: (-1.561, -0.857); [Formula: see text] < 0.001]. Furthermore, we observed that Chai-Hu-Shu-Gan Powder combined with SSRIs had a significant improvement on the depressive symptom in PD compared to the SSRIs alone [WMD: -5.390, 95% CI: (-7.66, -3.11); [Formula: see text] < 0.001]. No severe side events were reported in these included trials. This systematic review provided the evidences that TCM formulas combined with SSRIs might be helpful and safe in the treatment of depression of PD, including Chai-Hu-Shu-Gan Powder. Also, more randomized double-blinded trials with reliable design are required in the future.
Keywords: Depression; Herbal Formula; Meta-Analysis; Parkinson’s Disease; Selective Serotonin Reuptake Inhibitor; Systematic Review; Traditional Chinese Medicine.
Similar articles
-
Systematic review of traditional chinese medicine for depression in Parkinson's disease.Am J Chin Med. 2014;42(5):1035-51. doi: 10.1142/S0192415X14500657. Epub 2014 Sep 3. Am J Chin Med. 2014. PMID: 25183301
-
Traditional Chinese Medicine for non-motor symptoms in Parkinson disease: A systematic review and meta-analysis of RCTs.Medicine (Baltimore). 2023 Jul 28;102(30):e34425. doi: 10.1097/MD.0000000000034425. Medicine (Baltimore). 2023. PMID: 37505124 Free PMC article.
-
Selective serotonin reuptake inhibitors combined with traditional Chinese medicine for premature ejaculation: A systematic review and meta-analysis.Andrology. 2023 Jan;11(1):112-124. doi: 10.1111/andr.13307. Epub 2022 Oct 13. Andrology. 2023. PMID: 36193003
-
Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Parkinson's Disease: A Systematic Review and Meta-Analysis.Clin Drug Investig. 2024 Jul;44(7):459-469. doi: 10.1007/s40261-024-01378-8. Epub 2024 Jul 3. Clin Drug Investig. 2024. PMID: 38960993
-
Herbal Medicine Formulas for Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Double-Blind Placebo-Controlled Clinical Trials.Front Aging Neurosci. 2018 Nov 8;10:349. doi: 10.3389/fnagi.2018.00349. eCollection 2018. Front Aging Neurosci. 2018. PMID: 30467472 Free PMC article.
Cited by
-
Novel drug delivery strategies for antidepressant active ingredients from natural medicinal plants: the state of the art.J Nanobiotechnology. 2023 Oct 27;21(1):391. doi: 10.1186/s12951-023-02159-9. J Nanobiotechnology. 2023. PMID: 37884969 Free PMC article. Review.
-
Chinese Herbal Medicine in the Treatment of Depression in Parkinson's Disease: From Molecules to Systems.Front Pharmacol. 2022 Apr 13;13:879459. doi: 10.3389/fphar.2022.879459. eCollection 2022. Front Pharmacol. 2022. PMID: 35496318 Free PMC article. Review.
-
Parkinson's Disease and the Microbiota-Gut-Brain Axis: Metabolites, Mechanisms, and Innovative Therapeutic Strategies Targeting the Gut Microbiota.Mol Neurobiol. 2025 Apr;62(4):5273-5296. doi: 10.1007/s12035-024-04584-9. Epub 2024 Nov 12. Mol Neurobiol. 2025. PMID: 39531191 Review.
-
Transcriptome sequencing and network pharmacology-based approach to reveal the effect and mechanism of Ji Chuan Jian against Parkinson's disease.BMC Complement Med Ther. 2023 Jun 3;23(1):182. doi: 10.1186/s12906-023-03999-6. BMC Complement Med Ther. 2023. PMID: 37270490 Free PMC article.
-
A systematic review and meta-analysis of the efficacy of ketamine and esketamine on suicidal ideation in treatment-resistant depression.Eur J Clin Pharmacol. 2024 Feb;80(2):287-296. doi: 10.1007/s00228-023-03605-1. Epub 2023 Dec 20. Eur J Clin Pharmacol. 2024. PMID: 38117332
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical